CRF Connect Logo
  • Tracks & Learning Series
  • Conferences
  • My Favorites


Clinical Indications and Science

Clinical Trials & Science

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

Original Broadcast: October 25, 2023

Conference: TCT 2023

Late-Breaking Science Presenter: Pieter C. Smits

This website uses cookies to ensure you get the best experience on our website. Read More